BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ponroy Bally B, Murai KK. Astrocytes in Down Syndrome Across the Lifespan. Front Cell Neurosci 2021;15:702685. [PMID: 34483840 DOI: 10.3389/fncel.2021.702685] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 García O, Flores-aguilar L. Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease. Front Cell Neurosci 2022;16:987212. [DOI: 10.3389/fncel.2022.987212] [Reference Citation Analysis]
2 Berryer MH, Tegtmeyer M, Binan L, Valakh V, Nathanson A, Trendafilova D, Crouse E, Klein J, Meyer D, Pietiläinen O, Rapino F, Farhi SL, Rubin LL, Mccarroll SA, Nehme R, Barrett LE. Robust induction of functional astrocytes using NGN2 expression in human pluripotent stem cells.. [DOI: 10.1101/2022.09.07.507028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Martínez-cué C, Bartesaghi R. Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome? Nutrients 2022;14:2880. [DOI: 10.3390/nu14142880] [Reference Citation Analysis]
4 Farrell C, Mumford P, Wiseman FK. Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches. Front Neurosci 2022;16:909669. [DOI: 10.3389/fnins.2022.909669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Stagni F, Bartesaghi R. The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives. Front Cell Neurosci 2022;16:903729. [DOI: 10.3389/fncel.2022.903729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rapti G. Open Frontiers in Neural Cell Type Investigations; Lessons From Caenorhabditis elegans and Beyond, Toward a Multimodal Integration. Front Neurosci 2022;15:787753. [DOI: 10.3389/fnins.2021.787753] [Reference Citation Analysis]